It’s the coming together of best-in-class skills and get-it-done attitude that really sets Cooley apart. We know what’s worth fighting for.
About Danielle
Danielle represents emerging companies and venture capital investors in the formation and financing of high-growth life sciences/healthcare and technology companies. She has nearly 25 years of experience counseling emerging companies and their venture investors on a range of issues and transactions, including formation, venture capital financing, mergers and acquisitions, recapitalizations, spinouts, and general corporate matters, as well as representing companies in initial public offerings and various other public financing and strategic transactions.
Danielle is an active member of the National Venture Capital Association’s General Counsel Advisory Board and has regularly spoken about emerging companies and venture capital transactions for Practising Law Institute, various law schools and other organizations.
Recent representative investor-side deals
- G2VP:
- Series A and B investments in AssetWatch (formerly known as Nikola Labs)
- Series B investment in LightGuide Systems
- Series E investment in Locus Robotics
- Investments in SmarterX
- GIC Special Investments:
- Series E and Series F investments in Amplitude
- Series D investment in Brex
- Series G investment in Databricks
- Series E and G investments in Nubank
- Series D and E investments in Razorpay
- Series E investment in Stack Exchange
- Norwest Venture Partners:
- Series A investment in Abodu
- Series A investment in Anomalo
- Series A investment in Diagrid
- Series B investment in Diana Health
- Series A investment in Fabric
- Series D investment in Harness
- Series B investment in Homeward
- Series B investment in ICON
- Series A investment in Lavender
- Series A investment in Nanopath
- Series D investment in Nectero Medical
- Series B investment in Noyo
- Series A investment in Praxis Labs
- Series B investment in Session AI
- Series B investment in ShiraTronics
- Series B and Series C investment in Tempo
- Series B investment in Third Wave Automation
- Series C investment in Uptycs
- Redmile Group:
- Series F investment in Impulse Dynamics
- Series A investment in Orbital Therapeutics
- Series E investment in Saluda Medical
- Sonder Capital:
- Series B investment in Avail Medsystems
- Series C and D investments in Neptune Medical and associated spinout of Jupiter Endovascular
- Westbound Equity Fund:
- Seed Series investment in Conduit Tech
- SAFE investment in LaborUp
- Seed Series investment in Mon Ami
- Seed Series investment in Snoots
- Significant deal work for ARCH Venture Partners, Battery Ventures, and DCM, among others
Recent representative company-side deals
- Boostr in its $7 million Series A financing
- Inceptive Nucleics in its $20 million Series Seed financing and $100 million Series A financing
- InkSpace Imaging in its $11 million Series A financing
- Lisa Health in its $2.5 million Seed Series financing
- Novoloop in its $11 million Series A financing and $21 million Series A extension
- Protillion Biosciences in its $18 million Series A financing
- Quizizz in its $12.5 million Series A financing and $14.0 million Series B financing
- Slingshot Biosciences in its $23 million Series A financing and $11 million Series A-3 financing
- Visby Medical in its $135 million Series E financing
- Vontive in its $25 million Series B financing
Education
UCLA School of Law
JD, 2000
University of Michigan, Ann Arbor
AB, History, with honors, 1997
Rankings and accolades
Chambers USA: Venture Capital – California (2023, 2024)
Lawdragon: 500 Leading Dealmakers in America (2021, 2022, 2024, 2025)
YWCA of Silicon Valley: Tribute to Women in Industry
Northern California Super Lawyers: Rising Star